TABLE 4.

Univariate Analysis of Intubated Patients With and Without Ventilator-Associated Pneumonia

VAP (N = 30)No VAP (N = 595)P Value
n (%)n (%)
Male14 (46.6)337 (56.5).346
White22 (73.3)469 (78.7).161
Lung disease10 (33.3)122 (20.5).108
CHD8 (26.7)217 (36.4).332
Seizures2 (6.7)71 (11.9).562
Transplant4 (13.3)42 (7).267
Burn2 (6.7)2 (.34).0001
Immunodeficiency2 (6.7)11 (1.8).071
Genetic syndrome*12 (40)121 (20).010
Respiratory arrest6 (20)90 (15.1).470
Cardiopulmonary resuscitation3 (10)50 (8.4).762
Reintubation*17 (56.7)107 (17.9).0001
Tracheostomy*7 (23.3)35 (5.9).0001
Transfusion*22 (73.3)235 (39.4).0001
Transport out*20 (66.7)81 (13.6).0001
TPN*11 (36.7)102 (17.1).007
Steroids*15 (50)163 (27.3).008
H2 Blockers*14 (46.7)144 (24.2).006
Multiple CVC*13 (43.3)88 (14.7).0001
Cardiac repair5 (16.7)168 (28.2).164
Lung transplant2 (6.7)15 (2.5).175
Bronchoscopy*8 (26.7)48 (8.1).001
Cardiac catheterization1 (3.3)60 (10.1).222
Thoracentesis*3 (10)9 (1.5).001
Central line*8 (26.7)67 (11.2).012
Bloodstream infection*10 (33)46 (7.7).0001
Death6 (20)42 (7).065
Age (mean, y)3.53 ± 6.344.68 ± 5.88.632
PRISM score (mean)*11.64 ± 8.179.05 ± 6.24.036
PICU LOS (mean, d)*27.53 ± 20.095.93 ± 15.38.001
Hospital LOS (mean, d)*52.63 ± 37.4314.8 ± 30.87.002
  • CHD indicates congenital heart disease; CVC, central venous catheter; LOS, length of stay.

  • * Statistically significant.